Compositions and methods related to TIM-3, a TH1-specific cell surface molecule

Details for Australian Patent Application No. 2009202143 (hide)

Owner The Brigham and Women's Hospital, Inc. Dana-Farber Cancer Institute, Inc.

Inventors Monney, Laurent; Freeman, Gordon J.; Gaglia, Jason L.; Greenfield, Edward A.; Kuchroo, Vijay K.

Agent Davies Collison Cave

Pub. Number AU-A-2009202143

Parent 2003303082

Filing date 29 May 2009

Wipo publication date 18 June 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

18 June 2009 Application Open to Public Inspection

  Published as AU-A-2009202143

18 June 2009 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202144-Gaming system and method with wager variability

2009202142-Creation of user interface interactions